跳至主要内容
临床试验/ACTRN12611000655943
ACTRN12611000655943已完成1 期

A six-month supplementation of mulberry, Korean red ginseng and banaba decreases biomarkers of systemic low grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes

Sookmyung Women's University0 个研究点目标入组 94 人开始时间: 2011年6月27日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
35 Years 至 79 Years(—)
性别
All

入选标准

  • 1) Subjects diagnosed with the impaired glucose tolerence
  • 2) Subjects diagnosed with type 2 diabetes taking one or the combination of following mediations and have not changed the prescription for at least two months.
  • Mediations: sulfonylurea, biguanide, alpha-gludosidase
  • 3) Subjects with BMI over 20kg/m2, non-pregnant who has not taken herbs at least for last 3 months

排除标准

  • 1) Patients taking insulin or medications other than sulfonylurea, biguanide or alpha-glucosidase during last 2 months
  • 2)Individuals with chronic liver diseases, advanced kidney di se ases, atherosclerosis, myocardial infarction, pulmonary diseases, gastrointestinal diseases, hematological diseases and cancer
  • 3) Individuals receiving or have received pharmacological doses of steroids and/or participating weight reduction programs

研究者

相似试验